What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement
Equashield Leaderboard Banner (December 2025)

Press Release: CurifyLabs Launches CuraBlend®Vet, Bringing Breakthrough 3D-Printed, Personalized Medicines to Pets

Press Release: CurifyLabs Launches CuraBlend®Vet, Bringing Breakthrough 3D-Printed, Personalized Medicines to Pets

New flavored gel tablets are designed to look, feel, and taste like a treat to improve veterinary adherence 

Helsinki, Finland, and Jacksonville, FL – December 9, 2025 – CurifyLabs today announced CuraBlend® Vet, a new veterinary excipient system that enables 3D-printed, palatable, and personalized medicines for pets. Built for use with the CurifyLabs Compounding System Solution (CSS), CuraBlend®Vet brings a new level of quality, safety, and predictability to veterinary drug compounding. 

Veterinarians often lack dosage-specific medicines, forcing pharmacists to manually manipulate human drug products or prepare ad-hoc formulations. Such methods can be labor-intensive and introduce variability. Curablend Vet addresses these with a standardized, automated, and digitally documented 3D-printing workflow. Read More >

CurifyLabs

CurifyLabs News & Announcements

CurifyLabs Compounding System Solution (CSS) is an automated pharmaceutical compounding platform for non-sterile dosage forms, including tablets, troches, liquids, suppositories, ovules, ointments, and capsules. It enables better treatments for patients and improved efficiency for pharmacies and hospital pharmacies. In addition to cost savings, it ensures high manufacturing standards at the point of care through in-process quality control. 

The CSS is a user-friendly platform consisting of: GMP-manufactured excipient bases, compounding robotics, integrated quality control tools, software, and a comprehensive formulation library to meet the versatile compounding needs of pharmacies. CurifyLabs’ CSS technology is in use for patients by customers in 10 different markets in Europe and the US.

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes

Request information from Press Release: CurifyLabs Launches CuraBlend®Vet, Bringing Breakthrough 3D-Printed, Personalized Medicines to Pets

Name
Address
Subscribe